The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The global non-steroidal anti-inflammatory drugs market is expected to grow from $18.27 billion in 2022 to $19.57 billion in 2023 at a compound annual growth rate (CAGR) of 7.1%. The non-steroidal anti-inflammatory drugs market size is expected to grow to $24.88 billion in 2027 at a CAGR of 6.2%.

North America was the largest region in the non-steroidal anti-inflammatory drugs market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period.

Non-Steroidal Anti-Inflammatory Drugs Market Driver
The rising prevalence of chronic pain is likely to drive the expansion of the nonsteroidal anti-inflammatory medication market in the coming years. Chronic pain is defined as discomfort that lasts longer than six months. Nonsteroidal anti-inflammatory medications are used to manage chronic pain and mend injuries. According to the CDC (Centres for Disease Control and Prevention), a US-based government body, chronic pain was usually caused by arthritis in April 2022, affecting millions of people in the US. One in every four persons in a population of 15 million suffers from severe arthritis-related joint pain. As a result, the rising prevalence of chronic pain is propelling the nonsteroidal anti-inflammatory drug industry forward.

View More On The Non-Steroidal Anti-Inflammatory Drugs Market Report 2023 – https://www.thebusinessresearchcompany.com/report/non-steroidal-anti-inflammatory-drugs-global-market-report

Prominent Non-Steroidal Anti-Inflammatory Drugs Market Trend
Product innovation is a prominent trend in the market for nonsteroidal anti-inflammatory medicines. Major players in the nonsteroidal anti-inflammatory medicine industry are focusing on developing innovative technological solutions. For example, Ono and Seikagaku, a Japanese company that specialises in nonsteroidal anti-inflammatory medications, will offer JOYCLU, a 30 mg intra-articular injection, in May 2021. It is a formulation that combines hyaluronic acid and diclofenac (an anti-inflammatory drug) using Seikagaku’s unique technology. It is authorised for the treatment of osteoarthritis and is expected to improve symptoms after a four-week intra-articular injection. It is designed to release diclofenac in the joint via hydrolysis. Among joint function improvement medications, it is the first ethical drug in Japan with the indication of osteoarthritis of the hip joint.

Non-Steroidal Anti-Inflammatory Drugs Market Prominent Players
Major players in the non-steroidal anti-inflammatory drugs market are Pfizer Inc., Bayer AG, GSK plc, Dr. Reddy’s Laboratories Ltd., Viatris Inc., Teva Pharmaceutical Industries Ltd., Merck & Co Inc., Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Assertio Therapeutics Inc., Sanofi S.A., AstraZeneca, Horizon Therapeutics plc, Iroko Pharmaceuticals Inc., Reckitt Benckiser Group PLC, F. Hoffmann-La Roche Ltd., Mylan N.V., and Novartis AG.

Request A Sample Of The Global Non-Steroidal Anti-Inflammatory Drugs Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8023&type=smp

Key Non-Steroidal Anti-Inflammatory Drugs Market Segments
The global non-steroidal anti-inflammatory drugs market is segmented –
1) By Route of Administration: Oral, Topical, Other Route of Administration
2) By Disease Indication: Arthritis, Migraine, Ophthalmic Diseases, and Other Disease Indications
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

The Non-Steroidal Anti-Inflammatory Drugs Global Market Report 2023  provides a comprehensive overview on the non-steroidal anti-inflammatory drugs market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the non-steroidal anti-inflammatory drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
AntiHypertensive Drugs Global Market Report 2023
Antiemetics And Antinauseants Global Market Report 2023
Drugs For Immunotherapy Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model